F3 Platform Biologics, Inc. (JDRR)

F3 Platform Biologics was planning to go public, but the IPO was withdrawn on Jun 20, 2024.

Stock Price: Pending

IPO price not available yet

F3 Platform Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-1.09	-0.93	-2.21
Share-Based Compensation	-	-	1.88
Other Operating Activities	0.65	0.53	0.24
Operating Cash Flow	-0.45	-0.39	-0.1
Debt Issued / Paid	-	0.6	0.1
Financing Cash Flow	0.6	0.6	0.1
Net Cash Flow	0.15	0.21	0
Free Cash Flow	-0.45	-0.39	-0.1

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).